After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Department of Health and Human Services (HHS) secretary nominee Robert F. Kennedy Jr. plans to continue to receive referral fees from a law firm that is suing pharma powerhouse Merck & Co. | ...
Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...
One of the 30-second spots taps into the intensity of hit shows like “Game of Thrones.” It starts with a medieval royal preparing to go to war in the name of colorectal cancer screening, declaring, ...
The Preeclampsia Foundation has found a formula for closing the maternal health equity gap: Mix one part equity-forward preeclampsia education with one part low-dose aspirin prophylaxis and voilà, you ...
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market
With the purchase of a former Lonza biologics plant now in the books, San Francisco-based CDMO Joinn Biologics is expanding from one Bay Area to another. | CDMO Joinn Biologics has completed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback